While I do think this is a general move in the right direction, the cynic in me can't help but to think this recent spotlight on insulin in particular is a red herring to distract from the Democrats' inability to make headway on prescription drug and general healthcare affordability.
I mean, sure, diabetes is a big issue in the US, with type 2 being particularly problematic and prevalent among the least advantaged demographic groups, and efforts to keep insulin affordable will be massively beneficial to a relatively large number of people. But simply ensuring that insulin is affordable does nothing to address the underlying nutrition and healthcare access that lead so many to end up with type 2 diabetes in the first place.
The measure also seems woefully inadequate for addressing insulin access for the uninsured, which is going to dampen the effect as well.
I mean, sure, diabetes is a big issue in the US, with type 2 being particularly problematic and prevalent among the least advantaged demographic groups, and efforts to keep insulin affordable will be massively beneficial to a relatively large number of people. But simply ensuring that insulin is affordable does nothing to address the underlying nutrition and healthcare access that lead so many to end up with type 2 diabetes in the first place.
The measure also seems woefully inadequate for addressing insulin access for the uninsured, which is going to dampen the effect as well.